Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2022
Human endogenous retrovirus-K (HERV-K) reverse transcriptase (RT) structure and biochemistry reveals remarkable similarities to HIV-1 RT and opportunities for HERV-K-specific inhibitionEric T Baldwin, Matthias Götte, Egor P Tchesnokov, et al.Clinical Lung Cancer|January 24, 2012
Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early resultsBradford S Hoppe, Stella Flampouri, Randal H Henderson, et al.Acta Oncologica (Stockholm, Sweden)|May 19, 2017
Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis Bryant, Bradford S Hoppe, et al.International Journal of Radiation Oncology, Biology, Physics|November 25, 2010
Early outcomes from three prospective trials of image-guided proton therapy for prostate cancerNancy P Mendenhall, Zuofeng Li, Bradford S Hoppe, et al.Journal of Gastrointestinal Oncology|February 4, 2014
Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancerRovel J Colaco, Romaine Charles Nichols, Soon Huh, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2026
Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.Acta Oncologica (Stockholm, Sweden)|September 18, 2014
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancerThomas P Kole, R Charles Nichols, Song Lei, et al.Clinical Lung Cancer|July 6, 2011
Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric studyR Charles Nichols, Soon N Huh, Randal H Henderson, et al.Cancer Investigation|March 7, 2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate CancerR Charles Nichols, Christopher G Morris, Curtis Bryant, et al.Protein Science : a Publication of the Protein Society|October 2, 2007
Functional analysis of the GTPases EngA and YhbZ encoded by Salmonella typhimuriumHeather K Lamb, Paul Thompson, Catherine Elliott, et al.Pageof 6